Key Takeaways
- • Amwill Health Care Limited committed ₹3,00,00,000 (₹3 crore) to the Nippon India Credit Opportunities AIF Scheme II, a SEBI-registered Alternative Investment Fund, according to a BSE disclosure dated November 4, 2026.
- • The investment was approved by the company's Investment Committee on August 8, 2026, is within the stipulated limit, and will be funded through internal accruals with drawdowns in tranches.
- • The company stated that the AIF, its sponsor, and its manager are not related parties, indicating an arm's length transaction.
- • The disclosure was made under Regulation 30 of the SEBI Listing Regulations and the company's materiality policy.
Summary
Amwill Health Care Limited has announced a commitment of ₹3,00,00,000 (Rupees Three Crore) to the Nippon India Credit Opportunities AIF Scheme II, according to a disclosure published on BSE and dated November 4, 2026. The Alternative Investment Fund is SEBI-registered, and the commitment is part of the company's engagement with the vehicle as a strategic investment.
The investment was approved by the company's Investment Committee on August 8, 2026, and falls within the stipulated investment limit. Amwill Health Care stated that the commitment will be funded through internal accruals, with the amount to be drawn down in tranches rather than paid in a single lump sum.
The company emphasized that the AIF, its sponsor, and its manager are independent entities and not related parties to Amwill Health Care, which it said ensures an arm's length transaction. The disclosure was made in compliance with Regulation 30 of the SEBI Listing Regulations and the company's policy on determining materiality. Further details are to be made available on the company's website, www.amwillhealthcare.com.
The investment was approved by the company's Investment Committee on August 8, 2026, and falls within the stipulated investment limit. Amwill Health Care stated that the commitment will be funded through internal accruals, with the amount to be drawn down in tranches rather than paid in a single lump sum.
The company emphasized that the AIF, its sponsor, and its manager are independent entities and not related parties to Amwill Health Care, which it said ensures an arm's length transaction. The disclosure was made in compliance with Regulation 30 of the SEBI Listing Regulations and the company's policy on determining materiality. Further details are to be made available on the company's website, www.amwillhealthcare.com.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.